@article{661319378c5c4021b6f5180c463e2b6c,
title = "Reverse complement-PCR, an innovative and effective method for multiplexing forensically relevant single nucleotide polymorphism marker systems",
abstract = "DNA analyses from challenging samples such as touch evidence, hairs and skeletal remains push the limits of the current forensic DNA typing technologies. Reverse complement PCR (RC-PCR) is a novel, single-step PCR target enrichment method adapted to amplify degraded DNA. The sample preparation process involves a limited number of steps, decreasing the labor required for library preparation and reducing the possibility of contamination due to less sample manipulation. These features of the RC-PCR make the technology a unique application to successfully target single nucleotide polymorphisms (SNPs) in fragmented and low copy number DNA and yield results from samples in which no or limited data are obtained with standard DNA typing methods. The developed RC-PCR short amplicon 85 SNP-plex panel is a substantial improvement over the previously reported 27-plex RC-PCR multiplex that will provide higher discrimination power for challenging DNA sample analyses.",
keywords = "Forensic DNA, High sensitivity, Human identification, MPS, RC-PCR, SNPs",
author = "Bus, {Magdalena M.} and {de Jong}, {Erik A.C.} and King, {Jonathan L.} and {van der Vliet}, Walter and Joop Theelen and Bruce Budowle",
note = "Funding Information: This work was funded in part by award no. 2020-DQ-BX-0005, awarded by the National Institute of Justice (NIJ), Office of Justice Programs, US Department of Justice. The opinions, findings, and conclusions expressed within this publication are those of the authors and do not necessarily reflect those of the US Department of Justice. The authors affiliated with NimaGen BV disclose financial competing interests, as they are employees of NimaGen BV. The authors affiliated with the University of North Texas Center for Human Identification (UNTCHI) disclose no competing interests. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. Publisher Copyright: {\textcopyright} 2021 Future Science. All rights reserved.",
year = "2021",
month = sep,
doi = "10.2144/BTN-2021-0031",
language = "English",
volume = "71",
journal = "BioTechniques",
issn = "0736-6205",
publisher = "Eaton Publishing Company",
number = "3",
}